platelet therapy. In some patients, systemic anticoagulation may also be required.
Antiplatelet agents
Antiplatelet agents are generally used to treat patients
after lower extremity bypass. Although, antiplatelet therapy
has not been conclusively proven to improve bypass graft
patency, its beneﬁt in decreasing long-term postprocedural
adverse cardiovascular events is sufﬁcient indication for the
use of these agents in most patients, who are considered to
be